Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01181544

A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis

Renal Failure Chronic Requiring Hemodialysis Clinical Trial

Official title:
Heparin Dose Reduction During Hemodialysis With the Gambro Revaclear and Revaclear MAX Hemodialyzers: Pilot Study I and II

Clinical Trial Summary

During hemodialysis treatments, patients receive heparin to prevent clotting. The purpose of this pilot study is to determine if the amount of heparin administered during a patient's hemodialysis can be individualized using an equation for heparin dose adjustment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01181544
Study type Interventional
Source Baxter Healthcare Corporation
Contact
Status Completed
Phase N/A
Start date March 2011
Completion date August 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT01947673 - Mechanisms of Intradialytic Hypertension N/A
Not yet recruiting NCT03634904 - Serum Ceftazidime Concentrations in Hemodialysis Patients N/A
Terminated NCT01982864 - Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients. Phase 4
Completed NCT01448174 - Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients Phase 4
Completed NCT01421771 - Blood Pressure in Dialysis Patients N/A
Completed NCT01722695 - Performance Comparison of Revaclear With Larger Dialyzer N/A
Withdrawn NCT01015313 - Effects of Intensified Sodium Management in Hemodialysis Patients N/A
Not yet recruiting NCT02452788 - Pharmaceutical Care in Ambulatory Hemodialysis Patients N/A
Completed NCT02259413 - Effect of an Exercise Rehabilitation Program on Symptoms in Hemodialysis N/A
Recruiting NCT01356563 - Efficacy Study of Pharmacist Intervention on Medication-related Problems in Hemodialysis Patients N/A
Completed NCT01320202 - Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients Phase 3
Completed NCT02285075 - Temocillin Pharmacokinetic in Hemodialysis Phase 4
Completed NCT02825589 - BIA-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients N/A
Completed NCT00890045 - Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study N/A
Not yet recruiting NCT02264964 - Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis N/A
Completed NCT01214928 - Hemodialysis Vitamin D Pilot N/A
Terminated NCT01312441 - Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D Phase 4
Completed NCT00967993 - Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease Phase 2
Completed NCT01981603 - Transplant Navigator Dissemination N/A
Completed NCT01578421 - Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser N/A